Sort
48,018 grants matching “immunotherapy”
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$564,267Annick Desjardins · Duke University · P01 · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$564,243University Of Wisconsin Madison · U10 · FY2000 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$564,229Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Improving response durability after CAR T cell therapy for multiple myeloma
$564,221Michael C. Milone · University Of Pennsylvania · P01 · FY2025 · CA
Mechanisms controlling the persistence of infectious HIV reservoirs in children
$564,187Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2021 · HD
Intersection of alpha synuclein and tau contributions to neurotoxicity
$564,150Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2017 · NS
Intersection of alpha synuclein and tau contributions to neurotoxicity
$564,150Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2016 · NS
Intersection of alpha synuclein and tau contributions to neurotoxicity
$564,150Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2020 · NS
Intersection of alpha synuclein and tau contributions to neurotoxicity
$564,150Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2018 · NS
Intersection of alpha synuclein and tau contributions to neurotoxicity
$564,150Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2019 · NS
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer
$564,115Kenneth P Olive · Columbia University Health Sciences · R01 · FY2023 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$564,066Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2021 · CA
EFFECT OF OBESITY AND CHRONIC INFLAMMATION ON TRAIL-BASED IMMUNOTHERAPY FOR ADVANCE BREAST CANCER
$564,055Regents Of The University Of Minnesota · · FY2011 · Department of Defense
Immune response to Pneumocystis in simian model of AIDS
$564,003Karen A Norris · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL
Precision Targeting of CD1-Restricted iNKT Cells for Cancer Immunotherapy
$563,993Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Precision Targeting of CD1-Restricted iNKT Cells for Cancer Immunotherapy
$563,993Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Research Training in Academic Medical Oncology
$563,952Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2021 · CA
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$563,952Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2025 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
$563,904Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2024 · CA
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$563,902Michael Karin · University Of California, San Diego · R01 · FY2023 · CA
Conserved Element DNA Vaccine
$563,898Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria
$563,882Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
DIACYLGLYCEROL ACTIVATION OF T-CELL RECEPTOR SIGNALING FOR CANCER IMMUNOTHERAPY
$563,838Rector & Visitors Of The University Of Virginia · · FY2017 · Department of the Army
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$563,811Deborah W Knapp · Purdue University · U01 · FY2022 · CA
Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytes
$563,786Hanlee Ji · Stanford University · R01 · FY2025 · CA